US Stock MarketDetailed Quotes

Purple Biotech (PPBT)

Watchlist
  • 4.870
  • +0.800+19.66%
Close Apr 17 16:00 ET
  • 4.611
  • -0.259-5.32%
Post 19:32 ET
4.53MMarket Cap-0.09P/E (TTM)

Purple Biotech (PPBT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-35.43%6.98M
191.63%2.96M
-35.91%1.37M
-62.04%1.24M
-68.52%1.41M
-51.49%10.8M
-83.79%1.02M
-62.88%2.13M
-36.59%3.26M
-12.81%4.47M
Selling and administrative expenses
1.64%2.98M
181.61%873K
-0.64%780K
-21.04%683K
-38.06%646K
-39.41%2.94M
-50.95%310K
-32.21%785K
-39.51%865K
-35.78%1.04M
-General and administrative expense
1.64%2.98M
----
----
----
----
-39.41%2.94M
----
----
----
----
Research and development costs
-51.04%3.73M
299.13%1.83M
-56.45%587K
-76.87%553K
-77.80%760K
-55.27%7.62M
-91.26%458K
-70.63%1.35M
-35.47%2.39M
-2.14%3.42M
Depreciation amortization depletion
9.14%203K
----
----
----
----
-5.58%186K
----
----
----
----
-Depreciation and amortization
9.14%203K
----
----
----
----
-5.58%186K
----
----
----
----
Other operating expenses
-4.84%59K
----
----
----
----
-68.37%62K
----
----
----
----
Operating profit
35.43%-6.98M
-191.63%-2.96M
35.91%-1.37M
62.04%-1.24M
68.52%-1.41M
51.49%-10.8M
83.79%-1.02M
62.88%-2.13M
36.59%-3.26M
12.81%-4.47M
Net non-operating interest income expense
-254.25%-751K
-1,237.50%-963K
130.97%118K
-24.74%73K
-75.64%19K
87.58%-212K
97.22%-72K
-155.06%-381K
488.00%97K
-64.38%78K
Non-operating interest income
-12.69%227K
99.34%-1K
-5.38%123K
-39.67%73K
-43.16%54K
-45.15%260K
76.06%-152K
-81.64%130K
-1.63%121K
-65.83%95K
Non-operating interest expense
-4.88%39K
104.50%23K
-99.02%5K
--0
105.88%35K
-26.79%41K
-205.99%-511K
3,093.75%511K
-83.78%24K
-71.19%17K
Total other finance cost
117.87%939K
----
----
----
----
-79.72%431K
----
----
----
----
Other net income (expense)
-602.28%-18.77M
-3,029.57%-19.72M
-103.03%-56K
-90.05%74K
53.38%931K
-6.62%3.74M
673K
1.85M
744K
607K
Gain on sale of security
-56.40%1.72M
13.82%766K
-103.03%-56K
-92.18%74K
53.38%931K
-1.57%3.94M
--673K
--1.85M
--946K
--607K
Special income (charges)
-10,039.60%-20.48M
---20.48M
--0
--0
----
---202K
--0
--0
---202K
----
-Write off
10,039.60%20.48M
--20.48M
--0
--0
----
--202K
--0
--0
--202K
----
Income before tax
-263.95%-26.49M
-5,596.87%-23.64M
-95.36%-1.31M
54.91%-1.09M
87.94%-456K
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
22.88%-3.78M
Income tax
Net income
-263.95%-26.49M
-5,596.87%-23.64M
-95.36%-1.31M
54.91%-1.09M
87.94%-456K
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
22.88%-3.78M
Net income continuous Operations
-263.95%-26.49M
-5,596.87%-23.64M
-95.36%-1.31M
54.91%-1.09M
87.94%-456K
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
22.88%-3.78M
Minority interest income
-171.79%-106K
-1,840.00%-97K
60.00%-2K
60.00%-4K
84.21%-3K
59.79%-39K
83.87%-5K
73.68%-5K
54.55%-10K
24.00%-19K
Net income attributable to the parent company
-264.45%-26.39M
-5,642.68%-23.55M
-96.53%-1.3M
54.89%-1.09M
87.96%-453K
63.58%-7.24M
91.51%-410K
86.83%-663K
53.19%-2.41M
22.88%-3.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-264.45%-26.39M
-5,642.68%-23.55M
-96.53%-1.3M
54.89%-1.09M
87.96%-453K
63.58%-7.24M
91.51%-410K
86.83%-663K
53.19%-2.41M
22.88%-3.76M
Basic earnings per share
-22.73%-54
-12,512.88%-200
50.00%-2
77.78%-4
93.93%-340
75.28%-44
95.24%-1.5857
91.36%-4
64.00%-18
-11,100.00%-5.6K
Diluted earnings per share
-22.73%-54
-12,512.88%-200
50.00%-2
77.78%-4
93.93%-340
75.28%-44
95.24%-1.5857
91.36%-4
64.00%-18
-11,100.00%-5.6K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -35.43%6.98M191.63%2.96M-35.91%1.37M-62.04%1.24M-68.52%1.41M-51.49%10.8M-83.79%1.02M-62.88%2.13M-36.59%3.26M-12.81%4.47M
Selling and administrative expenses 1.64%2.98M181.61%873K-0.64%780K-21.04%683K-38.06%646K-39.41%2.94M-50.95%310K-32.21%785K-39.51%865K-35.78%1.04M
-General and administrative expense 1.64%2.98M-----------------39.41%2.94M----------------
Research and development costs -51.04%3.73M299.13%1.83M-56.45%587K-76.87%553K-77.80%760K-55.27%7.62M-91.26%458K-70.63%1.35M-35.47%2.39M-2.14%3.42M
Depreciation amortization depletion 9.14%203K-----------------5.58%186K----------------
-Depreciation and amortization 9.14%203K-----------------5.58%186K----------------
Other operating expenses -4.84%59K-----------------68.37%62K----------------
Operating profit 35.43%-6.98M-191.63%-2.96M35.91%-1.37M62.04%-1.24M68.52%-1.41M51.49%-10.8M83.79%-1.02M62.88%-2.13M36.59%-3.26M12.81%-4.47M
Net non-operating interest income expense -254.25%-751K-1,237.50%-963K130.97%118K-24.74%73K-75.64%19K87.58%-212K97.22%-72K-155.06%-381K488.00%97K-64.38%78K
Non-operating interest income -12.69%227K99.34%-1K-5.38%123K-39.67%73K-43.16%54K-45.15%260K76.06%-152K-81.64%130K-1.63%121K-65.83%95K
Non-operating interest expense -4.88%39K104.50%23K-99.02%5K--0105.88%35K-26.79%41K-205.99%-511K3,093.75%511K-83.78%24K-71.19%17K
Total other finance cost 117.87%939K-----------------79.72%431K----------------
Other net income (expense) -602.28%-18.77M-3,029.57%-19.72M-103.03%-56K-90.05%74K53.38%931K-6.62%3.74M673K1.85M744K607K
Gain on sale of security -56.40%1.72M13.82%766K-103.03%-56K-92.18%74K53.38%931K-1.57%3.94M--673K--1.85M--946K--607K
Special income (charges) -10,039.60%-20.48M---20.48M--0--0-------202K--0--0---202K----
-Write off 10,039.60%20.48M--20.48M--0--0------202K--0--0--202K----
Income before tax -263.95%-26.49M-5,596.87%-23.64M-95.36%-1.31M54.91%-1.09M87.94%-456K63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M22.88%-3.78M
Income tax
Net income -263.95%-26.49M-5,596.87%-23.64M-95.36%-1.31M54.91%-1.09M87.94%-456K63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M22.88%-3.78M
Net income continuous Operations -263.95%-26.49M-5,596.87%-23.64M-95.36%-1.31M54.91%-1.09M87.94%-456K63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M22.88%-3.78M
Minority interest income -171.79%-106K-1,840.00%-97K60.00%-2K60.00%-4K84.21%-3K59.79%-39K83.87%-5K73.68%-5K54.55%-10K24.00%-19K
Net income attributable to the parent company -264.45%-26.39M-5,642.68%-23.55M-96.53%-1.3M54.89%-1.09M87.96%-453K63.58%-7.24M91.51%-410K86.83%-663K53.19%-2.41M22.88%-3.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -264.45%-26.39M-5,642.68%-23.55M-96.53%-1.3M54.89%-1.09M87.96%-453K63.58%-7.24M91.51%-410K86.83%-663K53.19%-2.41M22.88%-3.76M
Basic earnings per share -22.73%-54-12,512.88%-20050.00%-277.78%-493.93%-34075.28%-4495.24%-1.585791.36%-464.00%-18-11,100.00%-5.6K
Diluted earnings per share -22.73%-54-12,512.88%-20050.00%-277.78%-493.93%-34075.28%-4495.24%-1.585791.36%-464.00%-18-11,100.00%-5.6K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More